Otoconin 90 inhibitors represent a specific class of chemicals that target the functional activity of Otoconin 90, a phosphoprotein integral to the biomineralization processes within the inner ear, specifically in the formation of otoconia. These inhibitors are characterized by their ability to interact with Otoconin 90, consequently impacting the protein's role in calcium binding and the formation of calcium carbonate crystals. The inhibition of Otoconin 90 can lead to alterations in the structure and function of otoconia, which are essential for gravity and motion sensing in the vestibular system of vertebrates. The chemical structure of these inhibitors is diverse, yet they share the commonality of being able to disrupt the normal function of Otoconin 90, either by direct interaction with the protein or by interfering with its expression or post-translational modifications.
The mechanism of action of Otoconin 90 inhibitors is varied, encompassing a range of chemical interactions. Some inhibitors may bind directly to the active or binding sites of Otoconin 90, thereby reducing the protein from interacting with its natural substrates or partners involved in otoconia formation. Others might interfere with the protein's structure, causing conformational changes that reduce its functional efficiency. Additionally, certain inhibitors might act indirectly by influencing the regulatory pathways that control the expression or activation of Otoconin 90. The inhibition can occur at different stages of the protein's life cycle, including synthesis, folding, transport, or degradation. The design and development of these inhibitors require a deep understanding of the biochemical pathways and molecular interactions involving Otoconin 90, as well as the physicochemical properties that govern the specific inhibitor-protein interactions. This class of inhibitors is of interest in the field of biochemistry and molecular biology, providing insights into the fundamental processes of biomineralization and protein function regulation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
EGTA | 67-42-5 | sc-3593 sc-3593A sc-3593B sc-3593C sc-3593D | 1 g 10 g 100 g 250 g 1 kg | $20.00 $62.00 $116.00 $246.00 $799.00 | 23 | |
Similar to EDTA, EGTA is more specific to calcium and could interfere with calcium-mediated processes. | ||||||
BAPTA, Free Acid | 85233-19-8 | sc-201508 sc-201508A | 100 mg 500 mg | $67.00 $262.00 | 10 | |
A calcium chelator that is more cell-permeable than EDTA or EGTA, potentially affecting intracellular calcium levels. | ||||||
Calmidazolium chloride | 57265-65-3 | sc-201494 sc-201494A | 10 mg 50 mg | $153.00 $600.00 | 27 | |
An inhibitor of calmodulin, a protein that interacts with calcium, thus indirectly influencing calcium-dependent pathways. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $58.00 $170.00 | 15 | |
A calcium channel blocker that might affect calcium homeostasis and therefore influence biomineralization. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $367.00 | ||
Another calcium channel blocker, potentially impacting calcium-dependent processes. | ||||||
Diltiazem | 42399-41-7 | sc-204726 sc-204726A | 1 g 5 g | $209.00 $464.00 | 4 | |
A calcium channel blocker that could indirectly affect calcium-dependent pathways. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
An inhibitor of the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), potentially disrupting calcium homeostasis. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $27.00 $52.00 | 37 | |
Modulates intracellular calcium levels, possibly affecting calcium-dependent processes. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $32.00 $66.00 $95.00 $188.00 $760.00 | 13 | |
Known to mobilize intracellular calcium stores, potentially impacting calcium signaling. | ||||||
Carbetocin | 37025-55-1 | sc-504618 | 10 mg | $330.00 | ||
Inhibits intracellular calcium release, potentially affecting calcium-dependent pathways. | ||||||